{"id":"https://genegraph.clinicalgenome.org/r/3719131f-c06b-4fd7-b8c0-f492dc0c9340v1.0","type":"EvidenceStrengthAssertion","dc:description":"PIGF was first reported in relation to onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (OORS), an autosomal recessive disorder in 2021 (Salian et al, PMID: 33386993). In this report, the same biallelic missense variant was identified by exome sequencing in two unrelated probands from the same geographical region of India (Salian et al, 2021, PMID: 33386993). The mechanism of pathogenicity appears to be loss of function, although data is limited. \nThis gene-disease relationship is also supported by experimental evidence, including the biochemical function of PIGF. PIGF appears to stabilize two different enzymes, PIGG and PIGO, which are responsible for the transfer of phoshoethanolamine to mannose residues during the synthesis of glycosylphosphatidylinositol (GPI), and essential process for the cell surface localization of GPI-anchored proteins (Inoue et al, 1993, PMID: 8463218; Hong et al, 2000, PMID: 10781593; Shishioh et al, 2005, PMID: 15632136; Kinoshita et al, 2024, PMID: 39129667). GPI-anchored proteins have been shown to be lacking on the cell surface of fibroblasts from patients with OORS, and variants in other genes involved in the GPI synthesis pathway have been identified in patients with overlapping clinical symptoms (Salian et al, 2021, PMID: 33386993). In summary, there is currently limited evidence supporting the relationship between PIGF and the autosomal recessive disorder known as OORS. This classification was approved by the ClinGen Congenital Disorders of Glycosylation Gene Curation Expert Panel on November 7, 2024  (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3719131f-c06b-4fd7-b8c0-f492dc0c9340","GCISnapshot":"https://genegraph.clinicalgenome.org/r/fee2ba7f-6e59-46a9-97b6-0d13c7513292","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/fee2ba7f-6e59-46a9-97b6-0d13c7513292_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-11-07T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/fee2ba7f-6e59-46a9-97b6-0d13c7513292_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-12-05T17:50:40.606Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fee2ba7f-6e59-46a9-97b6-0d13c7513292_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fee2ba7f-6e59-46a9-97b6-0d13c7513292_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2acfc83-e3b0-4601-9e8c-539df1498f32","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8aa1daf0-8734-4f12-b4e5-6221c6d2ba08","type":"Finding","dc:description":"This study identified domains of PIGF and are important generating GPI, and in binding PIGG and PIGO as part of this process.\nA later study showed that GPI-anchored proteins are not present on the cell surface in patients with biallelic variants in PIGF (Salian et al, 2020, PMID: 33386993). Therefore, a defect in PIGF could affect GPI synthesis, hence prevent GPI-anchored proteins being expressed on the surface of cells in affected individuals.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25074286","rdfs:label":"PIGF functional domains","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f7fce8bf-d430-439e-9e6d-deb94df945ec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92b204d4-c605-4120-a461-676842d211fb","type":"Finding","dc:description":"The authors cloned human PIGG (hGPI7), which is involved in the transfer of EtNP to the second mannose during GPI synthesis. PIGF was shown to bind and stabilize PIGG. Furthermore,\nPIGG (hGPI7) and PIGO compete for PIGF, providing a mechanism for regulation of GPI synthesis.\nA later study showed that GPI-anchored proteins are not present on the cell surface in patients with biallelic variants in PIGF (Salian et al, 2020, PMID: 33386993). Therefore, a defect in PIGF could affect GPI synthesis, hence prevent GPI-anchored proteins being expressed on the surface of cells in affected individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15632136","rdfs:label":"Role of PIGF (with PIGG, GPI7)","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2037245c-864c-44f6-9d46-891de469371c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9055682-5978-428a-bc4b-666817382aa9","type":"Finding","dc:description":"This study showed that PIGF is important in correct localization of proteins in the cell surface. A later study found that GPI-anchored proteins are not present on the cell surface in patients with biallelic variants in PIGF (Salian et al, 2020, PMID: 33386993). \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8463218","rdfs:label":"cloning of PIGF cDNA","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f174c8ac-f733-4321-afcb-7b5415d42740","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01c840ac-d1f2-47d6-8084-427afc72798b","type":"Finding","dc:description":"This study showed that PIFO and PIGF act together in transferring phosphoethanolamine to the third mannose during the process of GPI synthesis, and that PIGF is important in stabilizing PIGO, the enzyme involved in this process. A later study showed that GPI-anchored proteins are not present on the cell surface in patients with biallelic variants in PIGF (Salian et al, 2020, PMID: 33386993). Therefore, a defect in PIGF could affect GPI synthesis, hence prevent GPI-anchored proteins being expressed on the surface of cells in affected individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10781593","rdfs:label":"Role of PIGF (with PIGO)","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fee2ba7f-6e59-46a9-97b6-0d13c7513292_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/832e9a53-6b1a-412e-8ef5-842dbbac93f5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47f225c8-d728-4b9c-a159-86f966c3f80f","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47f225c8-d728-4b9c-a159-86f966c3f80f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometry analysis of GPI-anchored proteins CD59, uPAR, and CD55 in PIGF-deficient CHO cells transiently transfected with wildtype and mutant HA-tagged PIGF cDNAs revealed that the variant reduced the surface localization of these proteins; PIGF stability was not altered.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/47f225c8-d728-4b9c-a159-86f966c3f80f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386993","allele":{"id":"https://genegraph.clinicalgenome.org/r/abdf7754-a144-4c2a-b5a9-16fd48f4c602","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002643.4(PIGF):c.515C>G (p.Pro172Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346696363"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/832e9a53-6b1a-412e-8ef5-842dbbac93f5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386993","rdfs:label":"Salian_2021: Individual 2","ageType":"AgeAtReport","ageUnit":"Months","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/abdf7754-a144-4c2a-b5a9-16fd48f4c602"},"detectionMethod":"Sanger sequencing confirmed the presence of a homozygous variant in individual 2, and heterozygous status of the parents.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Tonic posturing noted since birth, but no clear seizures. \nAt 13 months, she has partial head control, does not reach for objects and does she look at faces. Anterior fontanelle was closed. Microstomia, micrognathia, coarse face, and short nose were noted.\nShe had hypoplastic convex nails on the thumb and the 5th digit, bilateral triphalangeal thumbs, hypoplastic toenails from 1st to 3rd digit, a complete absence of toenails on 4th and 5th digit. \nSee Fig 1 e-i for physical features.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/47f225c8-d728-4b9c-a159-86f966c3f80f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/32e9cc37-828e-4ab3-8b64-2a3f3a0e8ecc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f05a95b7-0ee8-462c-a2b6-8137d5eb8a58","type":"EvidenceLine","dc:description":"Function evidence in both PIGF-deficient CHO cells, and rescue in the patient's cells.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f05a95b7-0ee8-462c-a2b6-8137d5eb8a58_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometry analysis of GPI-anchored proteins CD59, uPAR, and CD55 in PIGF-deficient CHO cells transiently transfected with wildtype and mutant HA-tagged PIGF cDNAs revealed that the variant reduced the surface localization of these proteins; PIGF stability was not altered.\nTransfection of fibroblasts from Patient 1 with wild type PIGF cDNA restored cell surface expression of CD73. While this result is not specific to the variant, it supports that the patient has a defect in PIGF.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f05a95b7-0ee8-462c-a2b6-8137d5eb8a58_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386993","allele":{"id":"https://genegraph.clinicalgenome.org/r/abdf7754-a144-4c2a-b5a9-16fd48f4c602"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/32e9cc37-828e-4ab3-8b64-2a3f3a0e8ecc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386993","rdfs:label":"Salian_2021: Individual 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/abdf7754-a144-4c2a-b5a9-16fd48f4c602"},"detectionMethod":"Sanger sequencing confirmed the presence of a homozygous variant in Individual 1 and showed that the parents are heterozygous for the variant.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental delay, severe intellectual disability, hypoplastic fingernails, toenails and terminal phalanges, delayed permanent dentition, small teeth, anteverted nares, low-set pinna, open mouth, and atrial septum defect.\nHe has generalized tonicâ€“clonic seizures on a daily basis, refractory to medication.\nNo effective speech, cannot express needs, no toilet control. He displays head banging and repetitive non-purposeful rocking movements of head. He also has precocious puberty.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f05a95b7-0ee8-462c-a2b6-8137d5eb8a58_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Limited","sequence":9459,"specifiedBy":"GeneValidityCriteria11","strengthScore":5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/LXMfRLHo3B8","type":"GeneValidityProposition","disease":"obo:MONDO_0859161","gene":"hgnc:8962","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_fee2ba7f-6e59-46a9-97b6-0d13c7513292-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}